ARMISTICE CAPITAL, LLC - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 122 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2019$7,400,000
+8.2%
2,500,000
-41.9%
0.40%
-21.8%
Q4 2018$6,837,000
-7.1%
4,300,000
+115.0%
0.52%
+17.2%
Q3 2018$7,360,000
-35.0%
2,000,000
-50.0%
0.44%
-40.2%
Q2 2018$11,320,000
-29.0%
4,000,000
-6.9%
0.74%
-39.4%
Q1 2018$15,938,000
+248.0%
4,296,000
+321.2%
1.22%
+125.7%
Q3 2017$4,580,0001,020,0000.54%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q4 2018
NameSharesValueWeighting ↓
RA Capital Management 11,733,815$81,081,00011.64%
RTW INVESTMENTS, LP 2,589,818$17,896,0005.56%
DAFNA Capital Management LLC 480,300$3,319,0003.29%
DOHENY ASSET MANAGEMENT /CA 510,125$3,525,0001.83%
Sio Capital Management, LLC 364,368$2,518,0001.73%
TURNER INVESTMENTS LLC 1,086,000$7,504,0001.52%
Ghost Tree Capital, LLC 300,000$2,073,0000.93%
Rock Springs Capital Management LP 1,125,000$7,774,0000.63%
SENZAR ASSET MANAGEMENT, LLC 619,000$4,277,290,0000.62%
Point72 Asset Management, L.P. 9,772,018$67,525,0000.53%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders